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Highlights 
 The inhibition of cytochrome P450 due to azole fungicides can be estimated in vitro and 
to a lesser extent in silico for the insect larva C. riparius but not for the snail L. stagnalis.  
 Organisms may present very different enzymatic susceptibility toward azole inhibition, 
making species-species extrapolation not straightforward 
 
ABSTRACT 
Azole fungicides, designed to halt fungal growth by specific inhibition of fungal cytochrome 
P450 (CYP51), inhibit cytochrome P450s involved in the metabolism of xenobiotics in several 
non-target organisms thus raising environmental concern. The present study investigates the 
degree by which inhibition strengths of azoles toward cytochrome P450 in rat liver, the insect 
Chironomus riparius larvae and the snail Lymnaea stagnalis can be extrapolated from estimated 
in silico affinities. Azoles’ affinities toward human cytochrome P450 isoforms involved in 
xenobiotic metabolism (CYP3A4, CYP2C9 and CYP2D6) as well as fungal CYP51 were 
estimated with a ligand-protein docking model based on the ChemScore scoring function. 
Estimated affinities toward the selected enzymatic structures correlated strongly with measured 
inhibition strengths in rat liver (ChemScore vs. logIC50 among cytochrome P450 isoforms: -0.662 
< r < -0.891, n = 17 azoles), while weaker correlations were found for C. riparius larvae (-0.167 
< r < -0.733, n = 9) and L. stagnalis (-0.084 < r < -0.648, n = 8). Inhibition strengths toward C. 
riparius and rat liver activities were found to be highly correlated to each other (r: 0.857) while 
no significant relationship was found between either of the species and L. stagnalis. The 
inhibition of cytochrome P450 due to azole fungicides could be estimated in vitro and to a lesser 
extent in silico for C. riparius but not for L. stagnalis, possibly due to different enzymatic 
susceptibility toward azole inhibition among the species. 
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ABBREVIATIONS 
ACN, acetonitrile; BSA, bovine serum albumin; DTT, DL-dithiothreitol; ECOD, 7-
ethoxycoumarin-O-dealkylase; EDTA, ethylenediaminetetraacetic acid disodium salt dihydrate; 
IC50, half maximal inhibitory concentration; K2HPO4 3H2O, potassium phosphate dibasic 
trihydrate; KH2PO4, potassium dihydrogen phosphate; MFO Mixed function oxidase; NADPH, 
ß-nicotinamide adenine dinucleotide-phosphate reduced tetrasodium salt hydrate; PMSF, 
phenylmethanesulfonyl fluoride 
KEYWORDS 
Enzymatic assay, aquatic invertebrate, azole fungicide, in silico model, in vitro model 
 
1 Introduction 
Azole fungicides are a group of plant protection agents extensively use in agriculture, 
accounting for approximately 25 % of the total production of fungicides worldwide.1 
Furthermore, they are also used as antifungal drugs in humans as well as in livestock.2 Azole 
fungicides can enter surface water due to spray drift and run-off after rain events,3, 4 or through 
effluents of waste water treatment plants.2 Azoles have been measured in surface water in 
concentrations usually ranging from 0.01 μg/L to 1 μg/L with peak concentrations of up to 175 
μg/L.5  
Azoles were designed to inhibit the fungal cytochrome P450 responsible for ergosterol 
biosynthesis (CYP51, lanosterol-14 α-demethylase). Ergosterol plays an important role in the 
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function and integrity of fungal membrane, hence, inhibition of its synthesis halts fungal 
growth.6  The molecular structure of azoles is characterized by the presence of an azole ring, 
which contains either two (imidazoles) or three (triazoles) nitrogen atoms, resulting in different 
antifungal selectivity.7 However, in addition to the target cytochrome P450 of fungi, azoles have 
also been shown to inhibit cytochrome P450s involved in detoxification in non-target 
organisms.8-10 Inhibition of cytochrome P450 dependent detoxification is believed to be the main 
mechanism responsible for the ability of azoles to synergize the toxicity of other pesticides such 
as pyrethroid insecticides.8, 11 Under certain conditions, cytochrome P450s responsible for 
detoxification may also be induced thereby synergizing the toxicity of compounds that require 
activation by cytochrome P450 dependent oxidations to exert their toxic effect, such as certain 
organophosphate insecticides.12 Induction of cytochrome P450s is, however, not specifically 
related to azoles, but a more general property of several groups of xenobiotics,11 and it will 
therefore not be discussed further in the present study. 
Azoles reversibly inhibit cytochrome P450s by coordination of the azole ring to the heme-iron 
as well as through molecular interaction with the enzyme’s hydrophobic regions.13 In general, 
the inhibitory strength of azole fungicides toward cytochrome P450s is believed to be governed 
by several factors, namely the affinity of the nitrogen electron lone pair of the azole ring to the 
heme-iron  and the presence of substituents that may sterically modify this affinity, the 
hydrophobicity of the overall molecule (which is generally favorable for binding, given the 
hydrophobicity of the enzyme active cavity) and the complementarity between inhibitor 
geometry and enzyme active site.13  
A large suite of cytochrome P450s exists within the same organism, not only catalyzing 
xenobiotics but also a range of endogenous processes, of which those governing endocrine 
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hormone regulations have received the most attention.14-16 Cytochrome P450s involved in 
xenobiotic detoxification are membrane bound proteins primarily present in the endoplasmic 
reticulum (microsomal fraction) which mainly catalyze oxidation reactions.17, 18 Cytochrome 
P450s involved in detoxification generally lack the substrate specificity of cytochrome P450s 
involved in the metabolism of endogenous molecules. Different cytochrome P450s involved in 
detoxification have been shown to metabolize similar substrates and similar cytochrome P450s 
can metabolize different substrates.14-16  In the present study, the characterization of cytochrome 
P450 activity relevant for detoxification and its inhibition in different species is based on the 
ability of the extracted microsomal fraction to metabolize the same standard substrate, 7-
ethoxycoumarin.19   
Knowledge of inhibition strength of azole fungicides in relevant aquatic species would provide 
a tool to better understand and assess the ecotoxicological impact of these chemicals. Among the 
relevant aquatic species, the present study focuses on aquatic invertebrates, which are currently 
employed as test organisms for ecotoxicological studies and therefore form the basis of aquatic 
risk assessment of chemicals. Extraction of microsomal material and measurements of 
cytochrome P450 activities in small aquatic invertebrates used in ecotoxicological studies have 
been shown to be time consuming and sometimes not possible to carry out with current 
techniques. This is because organs rich in cytochrome P450s cannot be dissected out of very 
small organisms, and because homogenization of the whole organisms can release endogenous 
substances that attenuate in vitro enzymatic activity (Gottardi, et al. 20 and references therein). 
Therefore, the prediction of inhibition strengths, by using computer based approaches and/or by 
measurements on commercially available enzymatic materials extracted from other species, 
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could provide a quick and cheap screening tool to identify strong cytochrome P450 inhibitors 
and subsequently potential synergistic substances in environmental chemical mixtures.  
Ligand-protein docking is a well-established computer based (in silico) method that predicts 
the orientations of small organic molecules (ligands) in protein binding pockets21, 22 as well as 
their binding affinities in the form of docking scores.22 The method, although not free from 
limitations,21, 22 has been recently used to investigate inhibition of aromatase (cytochrome P450 
CYP19 involved in steroidogenesis) by azole fungicides, obtaining good degrees of correlation 
between docking scores and experimentally measured inhibition strengths of azoles toward 
aromatase activity in human (r: -0.81), fish brain (r: -0.69) and fish ovaries (r: -0.85).1 However, 
the use of this approach for ecotoxicologically relevant aquatic invertebrates presents additional 
limitations, since the specific types and roles of cytochrome P450 present in these organisms are 
generally unknown. Therefore, crystallized cytochrome P450 structures are currently not 
available and since gene sequencing of non-target invertebrates is only in its infancy, also the 
creation of cytochrome P450 structures from homology models is limited.23 At present, in silico 
investigations of chemical interactions with cytochrome P450s in aquatic invertebrates must 
therefore rely on the available (mainly human) cytochrome P450 crystallized structures.  
The use of models based on cytochrome P450 structures obtained from different organisms 
may nonetheless be possible. The overall three-dimensional structure of cytochrome P450s and 
the site responsible for the catalytic activity (heme-group) are conserved in practically all 
organisms where cytochrome P450s are found,18, 24 whereas the position of structural elements in 
the active cavity accounts for substrate and/or inhibitor (un)specificity among the different 
isoforms.18, 24 Therefore, inter species extrapolations of inhibition strengths may also be feasible 
for cytochrome P450s responsible for detoxification, as this group of enzymes is expected to 
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present substrate unspecificity and possibly to be conserved across species potentially exposed to 
the myriad of natural and artificial xenobiotics present in the environment. 
The aim of the present study was to investigate the degree by which an in silico ligand-protein 
docking model, based on available human and fungal cytochrome P450 crystallized structures, 
could estimate experimentally measured inhibition strengths of selected azole fungicides (Table 
1) toward microsomal cytochrome P450 activities of rat liver, insect Chironomus riparius larvae 
and snail Lymnaea stagnalis. Rat liver microsomes were chosen as a commercially available 
source of enzymatic material, widely used for in vitro cytochrome P450 activity assays. The non-
target invertebrates C. riparius and L. stagnalis were chosen as model organisms representing 
insects and molluscs, respectively. Both species are widely present in the environment and are 
currently used as standard organisms for ecotoxicological studies.25, 26 In addition, measurable 
cytochrome P450 activity of C. riparius has been shown to be inhibited by a range of azole 
fungicides in a previous investigation.20     
The present study tested the following hypotheses: 1) in silico estimated affinities (docking 
scores) between azoles and different cytochrome P450 isoforms are strongly correlated to one 
another; 2) the estimated affinities, based solely on the azoles’ molecular structures and the 
available crystallized cytochrome P450 structures, can be used to rank the inhibition strength of 
the azoles equally well in different species and 3) experimentally measured inhibition strengths 
of azole fungicides toward microsomal cytochrome P450 activities can be extrapolated between 
species from different phyla. 
2 Materials and Methods 
2.1 Azole fungicides and cytochrome P450 structures 
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Five imidazoles and 13 triazoles were selected based on their use in agriculture or medicine 
(Table 1, Figure S1). Their 3D structures were downloaded from the PubChem27 or ZINC28 
databases in Structure Data File (.sdf) format or Sybyl Mol2 (.mol2) format. 
A relatively large number of cytochrome P450 crystallized structures are available in The 
Protein Data Bank (PDB).29 Among those, the structures of three human cytochrome P450 
isoforms involved in xenobiotic detoxification were selected: CYP3A4, CYP2C9 and CYP2D6. 
Two crystallized structures were selected for each isoform, with or without the presence of a co-
crystallized inhibitor. This was done to investigate whether the choice of a specific isoform, or a 
structure co-crystallized with an inhibitor, had an effect on the correlations between the docking 
scores and the experimentally measured inhibition strengths of the azoles. CYP3A4 was selected 
due to its highest abundance in human liver,30 for which structures PDB 1TQN31 (due to its use 
by Tyzack, et al. 32) and 2V0M33 (co-crystallized with the inhibitor ketoconazole, PDB ID: KLN, 
Figure S2) were selected. CYP2C9 is reported to be the second highest abundant cytochrome 
P450 in human liver,30 for which structures PDB 1R9O34 (due to best resolution and previous use 
by Tyzack, et al. 32) and 4NZ235 (the newest structure available and co-crystallized with the 
inhibitor (2R)-N-[4-[(3-bromophenyl)sulfonyl]-2-chlorophenyl]- 3,3,3-trifluoro-2-hydroxy-2-
methylpropanamide, PDB ID: 2QJ, Figure S2) were selected. CYP2D6 was selected due to its 
involvement in the oxidation of approximately 25% of pharmaceutical drugs oxidized by 
cytochrome P450s,30 for which structures PDB 2F9Q,33 (due to previous use by Tyzack, et al. 32) 
and 4XRZ,36 (the newest structure available and co-crystallized with the inhibitor (4aR,6R,8aS)-
8a-(2,4-difluorophenyl)-6-(1H- pyrazol-4-yl)-4,4a,5,6,8,8a-hexahydropyrano[3,4- d][1,3]thiazin-
2-amine, PDB ID: SI6, Figure S2) were selected. Additionally, the fungal cytochrome P450 
isoform CYP51 was recently co-crystallized with several azole fungicides,37 of which structure 
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PDB 5EAB (co-crystallized with the inhibitor tebuconazole, PDB ID: TBX, Figure S2) was 
selected.  
2.2 Docking 
Prior to docking, the 3D structures of all azole stereoisomers were prepared with the LigPrep 
module in Maestro, v. 2014-238 by addition of hydrogen atoms and energy minimization of 
molecular geometries (bond lengths and angles). The selected cytochrome P450 structures were 
prepared with the built-in wizard of GOLD 5.439, 40 by addition of hydrogens and removal of co-
crystallized nonstandard residues (inhibitors, cofactors, ions, solvent and water molecules) if 
present.41  
Among the available scoring functions available in GOLD 5.439, 40, the ChemScore function 
was selected due to its parametrization with measured binding affinities42, 43 and available 
cytochrome P450 specific parameters44 as well as the ability to deconstruct binding energies in 
terms of different contributions, which are directly related to the factors governing the inhibitory 
strength of azole fungicides toward cytochrome P450s. The ChemScore function estimates the 
total free energy change (ΔGbinding) that results from ligand binding due to hydrogen bonds 
(ΔGhbond), metal bonds (ΔGmetal), lipophilic interactions (ΔGlipo) and non-rotatable ligand bonds 
(ΔGrot) (Equation 1) with the addition of penalties based on clashes due to close molecular 
contacts (DEclash), on internal torsion caused by poor internal conformation (DEint) and on user 
implemented constrains (DEcon) (dimensionless unit, Equation 2). 
ΔGbinding =  ΔG0  +  ΔGhbond  +  ΔGmetal  +  ΔGlipo  +  ΔGrot  Equation 1 
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Where ΔG0 = -5.48, ΔGhbond  = -3.34 * Shbond, ΔGmetal  = -6.03 * Smetal, ΔGlipo  = -0.117 * Slipo and 
ΔGrot  = 2.56 * Hrot  
ChemScore =  ΔGbinding  +  DEclash  +  DEint  +  DEcon Equation 2 
ChemScores were originated by two types of docking procedures: unconstrained docking and 
constrained docking.  Unconstrained docking served as a preliminary set up, run by keeping all 
parameters as default,41 and only changing the radius of the active cavity to 15 Å, in order to 
accommodate also the largest inhibitors in the dataset. To confirm the ability of the docking 
function to correctly predict binding poses, the co-crystallized inhibitors (Figure S2) were re-
docked into their relative CYP isoform structure. The predicted pose originated from 
unconstrained docking of three out of four co-crystallized inhibitors was visually comparable 
with their co-crystallized pose (Figure S3). However, the predicted poses of the selected azole 
fungicides by unconstrained docking were not comparable to the suggested inhibiting pose of 
azoles. Specifically, their predicted most energy favorable poses, into the entire active cavity of 
the selected cytochrome P450 structures, did not consistently position the nitrogen of the azole 
ring above the heme-iron of the enzyme active site (Figure 1A).  Constrained docking was 
therefore carried out by constraining the distance between the nitrogen in the azole ring and the 
heme-iron of the enzyme active site. This method positioned the azole molecules into the desired 
inhibiting pose (Figure 1B), with the distance between the nitrogen and heme-iron approximately 
within 1 to 2 Å, which is comparable to reported values.45 This was done by introducing a 
minimum and maximum separation equal to zero and one, respectively and a spring constant of 
10 in the built-in distance constraints options. In both docking procedures, ten poses were 
generated for each azole structure and the pose with the highest score was considered. An 
average score was calculated for compounds with two or more stereoisomers.    
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2.3 Organisms 
C. riparius larvae originally obtained from the Swedish University of Agricultural Sciences, 
Sweden, were cultured based on the OECD Guideline for Testing of Chemicals.26 During 
culturing, the organisms were kept in 5 L crystalline dishes containing constantly aerated M7 
medium (of approximately 8 cm depth) and quartz sand (of approximately 1 cm depth) at 20 ± 2 
°C with 16:8 hour light: dark photoperiods. Evaporated water from the medium was replaced 
with demineralized water to maintain the ion balance; moreover, 1 L of water was changed once 
a week to remove excess nutrients. The larvae were fed with 0.15 g of Tubifex® Biotal Basic 
Vegetable flakes per crystalline dish, three times a week. 
L. stagnalis originally obtained from the University of southern Denmark, Denmark, were 
cultured based on the OECD Guideline for Testing of Chemicals.25 The organisms used for the 
following experiments originated from eggs collected from the main culture aquarium two times 
a week for two weeks and kept in a 12 L aquarium containing constantly aerated tap water and 
CaCO3 rich sand (of approximately 1 cm depth) at 20 ± 2 °C with 16:8 hour light: dark 
photoperiods. After hatching, organisms were fed with visually suitable amounts of organic 
lettuce and Tubifex® Biotal Basic Vegetable flakes, two times a week. 
2.4 Chemicals 
Azole fungicides used in the present study were bought from Sigma-Aldrich and are 
summarized in Table 1 together with their type, use, CAS number, purity, molecular weight, 
predicted logP (computed by Chemicalize,46 based on Viswanadhan, et al. 47) and number of 
isomers. The standard substrate for 7-ethoxycoumarin-O-dealkylase (ECOD) activity of 
cytochrome P450: 7-ethoxycoumarin (CAS: 31005-02-4, purity: 99.7%) and its product: 7-
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hydroxycoumarin (CAS: 93-35-6, purity: 99.5%) were obtained from Sigma-Aldrich. Potassium 
dihydrogen phosphate (KH2PO4, CAS: 7778-770, purity: ≥  99.0 %) and 
ethylenediaminetetraacetic acid disodium salt dihydrate (EDTA, CAS: 6381-92-6, purity: 99.0 
%) were bought from VWR - Bie & Berntsen. Potassium phosphate dibasic trihydrate 
(K2HPO4*3H2O, CAS: 16788-57-1, purity: ≥  99.0 %) was obtained from Merck and acetonitrile 
(ACN, CAS: 75-05-8, purity: ≥  99.9 %) from Rathburn. Bovine serum albumin (BSA, CAS: 
9048-46-8, purity: ≥  98 %), Bradford reagent (Product nr: M9066), ß-nicotinamide adenine 
dinucleotide 2'-phosphate reduced tetrasodium salt hydrate (NADPH, CAS: 2646-71-1, purity: 
≥  98 %), 2-methoxyethanol (CAS: 109-86-4, purity: ≥  99.9 %), DL-dithiothreitol (DTT, CAS: 
03-12-3483, purity: ≥  99.5 %), glycerol (CAS: 56-81-5, purity: ≥  99 %), 
phenylmethanesulfonyl fluoride (PMSF, CAS: 329-98-6, purity: ≥  99.0 %) were obtained from 
Sigma-Aldrich.  
Rat liver microsomes (Product nr: M9066, pooled from male rat) were bought from Sigma-
Aldrich. Phosphate buffer (0.30 M) was prepared with KH2PO4 (final conc. in buffer: 0.10 M) 
and K2HPO4*3H2O (final conc. in buffer: 0.20 M) in water from a MilliQ system. Stock solution 
of 7-ethoxycoumarin (25 mM) was prepared in 30 % v/v ACN in MilliQ water while stock 
solution of 7-hydroxycoumarin (3.6 mM) in 100 % v/v ACN. The stock solutions of BSA (5 mg 
mL-1) and NADPH (2 mM) were prepared in phosphate buffer (0.13 M, pH 7.5), of PMSF in 2-
methoxyethanol (100 %) and of DTT (50 mM) and EDTA (10 mM) in MilliQ water. Stock 
solutions of azoles were prepared in 100 % v/v ACN.  
2.5 Microsomes preparation 
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Microsomes were prepared as described in Gottardi, et al. 20. In short, four instar C. riparius 
larvae (approximately 10 mm in length) or randomly selected L. stagnalis (approximately 15 mm 
in length) were snap frozen in liquid nitrogen and stored at -80 °C. In a single 1.5 mL vial, whole 
C. riparius (5 organisms) larvae or half L. stagnalis (after removing the foot, the remaining 
material was divided into two vials) were homogenized in ice cold homogenization buffer (Tot. 
vol. 1 mL) containing phosphate buffer (0.13 M, pH 7.5), EDTA  (1 mM), PMSF (1 mM), DTT 
(1 mM) and glycerol (10 % v/v). Homogenization was first performed with a tissue grinder 
(Econo Grind, Radnoti, U.S.) until the organisms were largely disrupted. After that, further 
homogenization was carried out with an ultrasonic stick (Digital Sonifier cell disruptor Model 
450, Branson Ultrasonics, U.S.) on ice (3 pulses of 3 seconds each, 10 seconds pause between 
pulses, 20 % amplitude). The homogenate was centrifuged (Optima TM MAX-XP 
Ultracentrifuge, Beckman Coulter, U.S.) at 10000 g for 15 min at 4 °C; the supernatant was 
collected and further centrifuged at 100000 g for 50 min at 4 °C. The resulting pellets containing 
the microsomes were re-suspended (with an ultrasonic stick using 1 to 2 pulses of 3 seconds 
each, 10 seconds pauses and 10 % amplitude) in 350 μL phosphate buffer (0.13 M, pH 7.5) and 
glycerol (10 % v/v) on ice. Microsomes obtained from multiple vials were pooled into a single 
batch and stored at -80 °C. 
2.6 Protein content 
Protein content was determined according to Bradford 48 by use of a multi-mode microplate 
reader (SpectraMax i3 Microplate Reader, Molecular Devices, U.S.). Re-suspended microsomes 
(5 µL) were incubated with 250 µL Bradford reagent at room temperature for 10 – 15 minutes. 
Absorbance was then measured at 595 nm in a transparent microwell plate (Greiner Bio-one flat 
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bottom 96-well plate, VWR) and protein content quantified using a bovine serum albumin (BSA) 
standard dilution series (0 - 1.4 mg protein mL-1 BSA in phosphate buffer 0.13 M, pH 7.5). 
2.7 Activity and inhibition measurements 
Activity measurements were based on the method described by Gottardi, et al. 20 Microsomes 
from rat-liver (50 μL, final concentration: 0.03 mg microsomal protein mL-1), C. riparius (50 μL, 
final concentration: 0.16 microsomal protein mL-1) and L. stagnalis (50 μL, final concentration: 
0.16 microsomal protein mL-1) were incubated with phosphate buffer (0.1 M, pH 7.5), NADPH 
(0.0156 mM for rat liver and 0.025 mM for C. riparius and L. stagnalis), 7-ethoxycoumarin (0.6 
mM for rat liver and 0.3 mM for C. riparius and L. stagnalis) and 5 μL of azole (n = 2 or 3 
analytical replicates for rat liver, n = 3 for C. riparius and L. stagnalis) or 5 μL solvent (control, n 
= 2 or 3 analytical replicates for rat liver, n = 6 for C. riparius and n = 4 for L. stagnalis) in a 
total volume of 255 μL. Blanks were made with all reagents except the substrate in order to 
account for background fluorescence of NADPH49 and with re-suspended microsomes (50 μL) in 
order to maintain the same density and fluorescence attenuation of the medium. Fluorescence 
increase due to 7-hydroxycoumarin formation (excitation: 380 nm, emission: 480 nm) was 
measured every 30 seconds for 30 minutes for rat liver or every 1 minute for 60 minutes for C. 
riparius and L. stagnalis in a black microwell plate (BRANDplates® pureGradeTM, Brand, 
Germany) with a multi-mode microplate reader (SpectraMax i3 Microplate Reader, Molecular 
Devices, U.S.) at 37 °C.  
Measurements of inhibition with rat liver microsomes were carried out with all the 18 azoles 
selected in the present study, out of those, the 5 imidazoles and the 6 and 5 most potent triazoles 
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were selected for measurements of inhibition in C. riparius and L. stagnalis microsomes, 
respectively.  
2.8 Experimental determination of inhibition strength (half maximal inhibitory concentrations, 
IC50) 
Fluorescence measured over time was corrected by subtracting the average fluorescence 
measured in the blanks over time. Cytochrome P450 activity (change in fluorescence per unit of 
time) was determined as the slope of a linear regression fitted with Sigma Plot version 13 
(Systat) in the linear range of fluorescent product formation.  
7-ethoxycoumarin-O-dealkylase (ECOD) activity in the presence of an inhibitor was expressed 
as percentages relative to control activity (without the addition of azole fungicide, 100 % 
activity). Estimation of half maximal inhibitory concentration (IC50) was carried out by fitting a 
two parameters log-logistic model (Equation 3) in RStudio version 1.0.143 with the drc-
package.50  
𝑦 =  
100
1+ (
𝑥
𝐼𝐶50
)
𝑏 Equation 3 
where x is the concentration of inhibitor (µM), y is the ECOD activity relative to control (in 
percent), IC50 is the half maximal inhibitory concentration (in µM) and b is a factor describing 
the slope around IC50.  
Background control activities were quantified with measurements of product (7-
hydroxycoumarin) fluorescence and converted to pmol min-1 mg microsomal protein-1 by 
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conversion factors of 1.79 105, 1.59 105 and 1.86 105 relative fluorescence units pmol-1, for rat, 
C. riparius and L. stagnalis, respectively. 
2.9 Statistical analysis 
The estimated IC50 values were log-transformed prior to any analysis in order to obtain normal 
distribution around the mean. Normal distribution around the mean of estimated IC50 values and 
docking scores were checked with the Kolmogorov-Smirnov test (normal distribution with 
p>0.05). Correlations between estimated IC50 values and docking scores were analysed with 
Pearson (parametric test) or Spearman (non-parametric) test in case of normally or not normally 
distributed docking scores, respectively (significant correlations with p<0.05). Differences 
between correlations were analysed with Fisher Z-test for equality of correlations (significant 
differences with p<0.05). Regression analysis between the estimated IC50 values in rat liver, C. 
riparius and L. stagnalis was carried out after checking for equality of variances (F test, equal 
variances with p>0.05). Mystat version 12.02.00 (Systat) was used for all statistical analysis. 
3 Results and discussion  
3.1 In silico estimated affinities and correlation to rat liver cytochrome P450 inhibition 
Unconstrained docking predicted the most energy favorable pose of the azole fungicides into 
the entire active cavity of the selected cytochrome P450 structures while constrained docking 
positioned the azoles into their inhibiting pose, allowing the estimation of affinities between the 
azoles in their inhibiting pose and the space adjacent to the reaction site. Unconstrained docking 
scores are on average 19 ChemScore units higher than constrained docking scores, generally due 
to higher predicted penalties for constrained docking as compared to unconstrained docking (data 
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not shown). Docking scores originating from unconstrained and constrained docking are strongly 
correlated to each other for all cytochrome P450 structures used (0.709 < r < 0.987, p < 0.05; 
Figure S3). Nonetheless, due to the particular biological relevance of the constrained poses, as 
compared to the apparently irrelevant unconstrained poses when investigating inhibition 
strengths of azole fungicides, only constrained docking scores are considered in the following.  
Docking scores of selected azoles vary for up to 25 ChemScore units from each other within a 
single cytochrome P450 structure (Table S4). Moreover, docking scores of a single azole vary 
for up to 46 ChemScore units between different cytochrome P450 structures (Table S4). This 
suggests the ability of the present model to identify differences among the selected azoles as well 
as between the cytochrome P450 structures used. Nonetheless, docking scores are strongly 
correlated to one another across all cytochrome P450 structures used (0.527 < r < 0.980, p < 
0.05; Figure S4 and S5) and anticorrelate strongly and significantly with the experimentally 
determined inhibition strengths (IC50) in rat liver (-0.662 < r < -0.891, p < 0.05; Figure 2), with 
exception of clotrimazole. The correlations between docking scores and measured inhibition 
strengths are not significantly different among one another (Z-test, p>0.05), among the different 
cytochrome P450 isoforms or structures used. Furthermore, the correlations are only marginally 
stronger (on average 3 to 9 % higher correlation coefficients) for the enzymatic structures 
crystallized with an inhibitor (CYP2C9 4NZ2, CYP3A4 2V0M and CYP2D6 4XRZ), as 
compared to their counterpart with no co-crystallized inhibitor (CYP2C9 1R9O, CYP3A4 1TQN 
and CYP2D6 2F9Q). Taken together, the choice of neither a specific cytochrome P450 isoform 
nor a specific crystallized structure within the same isoform has a significant effect on the 
correlations obtained between docking scores and measured inhibition strengths, supporting the 
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hypothesis that the affinities between the selected azoles and cytochrome P450 isoforms are 
strongly correlated to one another. 
Although not significantly different among one another, the correlation between docking 
scores and measured inhibition strengths are strongest for the human CYP2C9 (r: -0.891 for 
structure 4NZ2 and r: -0.835 for structure 1R9O), followed by human CYP3A4 (r: -0.859 for 
structure 2V0M and r: -0.835 for structure 1TQN) and fungal CYP51 (r: -0.824) and weakest for 
human CYP2D6 (r: -0.721 for structure 4XRZ and r: -0.662 for structure 2F9Q). This seems to 
agree with the relative size of human cytochrome P450 active cavities, being largest for CYP2C9 
and CYP3A4 and relatively smaller for CYP2D6, and with the lipophilicity of the active pockets, 
being highest for CYP2C9, followed by CYP3A4 and lastly 2D6.22  
In order to examine which interactions are predicted to play the major contribution to the 
docking scores of the selected azoles toward the cytochrome P450 structures, the correlations 
between scores and scoring function single terms (Equation 1 and Equation 2) were analysed 
(Tables S5 – S11 and Figures S6 – S12). The predicted metal interaction (Smetal, Equation 1) is 
equal for all azole fungicides structures and it has a value of 0 or 0.9 depending on the 
cytochrome P450 structure used for docking. This is possibly due to lack of resolution of the 
scoring function. Conversely, the predicted lipophilic interaction (Slipo, Equation 1) is the term 
which correlates the most with the docking scores for all cytochrome P450 structures used (0.433 
< r < 0.966, p < 0.05). The term is based on the number of non-polar carbon, non-accepting 
sulphur, non-ionic bromine, chlorine and iodine atoms of the ligand and the enzymatic active 
site,42, 43 therefore depending strongly on the nature of their three-dimensional structures. This is 
in agreement with the reported strong correlation between azole affinities toward CYP3A and 
CYP2B and their lipophilicity expressed as logP (pIC50 and logP, r: 0.988).51 In the present study 
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and in the context of the scoring function used, we conclude that in silico estimated affinities of 
the selected azoles depends mainly on their ability to lipophilically interact with the enzyme 
active cavities.  
3.2 In silico estimated affinities and extrapolation to insects and molluscs 
Correlations between docking scores and experimentally determined inhibition strengths (IC50) 
in C. riparius are weaker than those for rat liver (-0.286 < r < -0.733; Figure 3) and significant 
for one of the seven cytochrome P450 structure tested (p > 0.05 except for CYP2C9 4NZ2). This 
may be due to a hypothetical more similar composition and/or susceptibility of cytochrome 
P450s between humans and rats, as compared to humans and insects.15, 52, 53 Moreover, the 
correlations is even weaker and not significant for L. stagnalis (-0.084 < r < -0.593, p > 0.05; 
Figure 4). In addition to clotrimazole, ketoconazole presents outlier behaviour in both species. In 
silico estimated affinities seem able to correctly rank azole fungicides in terms of their inhibition 
strength toward cytochrome P450 activities of rat liver, and to a lesser extent of C. riparius, 
while failing in the case of L. stagnalis. This rejects the hypothesis that in silico estimated 
affinities can be used to rank azole fungicides inhibition strengths toward cytochrome P450 
activities equally well in different species. 
3.3 Comparing measured inhibition strengths between species  
In the present study, measured background ECOD activity of rat liver is equal to 625 pmol 
min-1 mg microsomal protein-1, background C. riparius activity ranges between 5 and 29 pmol 
min-1 mg microsomal protein-1 in different microsomes batches, while background activity of L. 
stagnalis is 8 pmol min-1 mg microsomal protein-1. This suggests comparable degrees of 
activities between C. riparius and L. stagnalis and 20 to 125-folds higher activities in rat liver 
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microsomes as compared to the other two species. Comparable cytochrome P450 ECOD 
activities have been reported for rat liver microsomes (approximately 2000 pmol min-1 mg 
microsomal protein-1),54 as well as C. riparius (0.5 to 1 pmol min-1 mg microsomal protein-1),55 
while reported cytochrome P450 ECOD activities seem to be lacking for L. stagnalis. The reason 
for the difference in enzymatic activity per microsomal protein of rat as compared to 
invertebrates is most likely that rat microsomes are isolated from the liver, known to be the organ 
with one of the highest concentrations of detoxification enzymes, while invertebrate microsomes 
are isolated from whole organisms.  
The ability of the selected azole fungicides to inhibit measured cytochrome P450 activity 
depends both on the azole fungicide and the selected species (Table 1 and dose response curves 
in Figures S10, S11 and S12). Comparable inhibitory concentrations in the µM range have been 
previously reported towards rat liver CYP2B and CYP3A activities,51 fungal growth 37 and 
human as well as fish aromatase (CYP19).1 On the other hand, inhibition of microsomal 
cytochrome P450 activity of C. riparius and L. stagnalis due to azole fungicides is, to the best of 
our knowledge, not yet available. IC50 values for rat liver (0.0032 – 26 µM) and C. riparius 
(0.074 – 18 µM) are within the same range. L. stagnalis microsomes presents up to three orders 
of magnitude higher IC50 values (2.3 – 142 µM) as compared to rat liver and C. riparius (Table 
1), showing lower susceptibility toward inhibition by azoles as compared to the two other 
species.  
Inhibition strengths of the selected azole fungicides measured in C. riparius are strongly 
correlated to the strengths measured in rat liver (r: 0.857, p: 0.002; Figure 5). It seems possible to 
extrapolate the relative strengths of azole fungicides toward cytochrome P450 activity in C. 
riparius from measurements carried out in rat liver, as approximately 70% of the variation in C. 
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riparius can be described by the measurements in rat liver (R2: 0.734, Figure 5). On the other 
hand, as expected, no significant relationship is found between inhibition strengths toward rat 
liver and L. stagnalis or toward C. riparius and L. stagnalis (Figure 5), rejecting the hypothesis 
that the measured inhibition strengths of azole fungicides toward microsomal cytochrome P450 
activities can be extrapolated between species of different phyla.  
3.4 Method limitations 
The variation between the estimated in silico affinities and measured inhibition strengths of the 
selected azoles against cytochrome P450 activity of different organisms can have several causes, 
due to a number of aspects not accounted for by the models used in the present study.   
The substrate 7-ethoxycoumarin, shown to be unspecific for human cytochrome P450s 
involved in detoxification,56 should cover the activity of several cytochrome P450 isoforms. 
However, to the best of our knowledge, its selectivity for cytochrome P450 isoforms present in 
C. riparius and L. stagnalis is unknown. The specific cytochrome P450(s) able to metabolize the 
substrate 7-ethoxycoumarin in the different species may present substantial differences. 
Therefore, azoles may inhibit cytochrome P450 catalyzed oxidations not measured with the 
selected in vitro model, as for example hydroxylation reactions or may inhibit diverse 
cytochrome P450s with ECOD activities in the different species, adding uncertainties to the 
measured inhibition strengths and their inter-species correlations.  
The majority of the azole fungicides selected has several stereoisomers. It has been reported 
that the binding affinities and inhibition strengths among stereoisomers may be different, 
depending on their structural differences and/or the target enzymatic system/organism.37, 57, 58 In 
the present study, docking scores of stereoisomers varies for up to 11 ChemScore units from 
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each other (Table S2 and S4). However, measurements of inhibition strengths are carried out 
with racemic mixtures, so it is not possible to compare estimated affinity and inhibition strength 
of each separate stereoisomer. It is important to keep in mind that the relative part played by each 
stereoisomer toward inhibition may be different, adding uncertainties to the correlation between 
measured inhibition strengths and estimated affinities of racemic mixtures.  
Metabolism of azole fungicides may have taken place already during measurements of 
inhibition strengths in rat liver microsomes as well as in the microsomes extracted from C. 
riparius and L. stagnalis, as azole fungicides have been reported to be readily metabolized by rat 
liver microsomes.59 The potential formation of metabolites which are able to interact with 
cytochrome P450s more or less potently than the parent compound adds further uncertainties to 
measurement of inhibition strengths and estimated affinities. This may explain the different 
inhibition strengths of clotrimazole and ketoconazole toward cytochrome P450 activity among 
the different species, and their resulting outlier behaviour (Figure 2, 3, 4 and 5). In particular, 
docking scores of clotrimazole toward the selected cytochrome P450 structures are generally 
underestimated as compared to the inhibition strength and are much lower than the scores of the 
other imidazoles (approximately 60 to 250 % lower than the average of all imidazoles for five 
out of the seven cytochrome P450 structures used). The low docking scores seems to be due to 
high clashing terms (DEclash, Equation 2) and/or absence or low hydrogen bond interaction 
(Shbond, Equation 2; Table S6, S7, S8, S9 and S10). The discrepancy observed between docking 
scores and inhibition strength of clotrimazole may be due to formation of metabolites with higher 
affinity and consequential stronger inhibition strength toward cytochrome P450 activity than 
estimated for the parent compound. In the present study, however, even though cytochrome P450 
structures are selected with or without the presence of a co-crystallized inhibitor, the in silico 
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model does not directly consider the flexibility of cytochrome P450 active cavities. It has been 
previously reported for mammalian cytochrome P450s,60 that the position of structural elements 
in the active cavity can change upon ligand binding. In the real situation, this may reduce any 
predicted clash due to close molecular contacts and allow even the relatively larger and more 
cumbersome ligands to be accommodated into the active pocket.  
Docking scores of ketoconazole are overestimated as compared to its inhibition strength in C. 
riparius and L. stagnalis (Figure 3 and 4) but not in rat liver (Figure 2). The compound is the 
largest molecule investigated and has the highest docking scores among all azoles in the present 
study (Table S2 and S4) independently on which cytochrome P450 structure is used for docking. 
Its inhibition strength is different among the species, approximately 50 % to four orders of 
magnitude weaker toward activities in C. riparius and L. stagnalis than toward rat liver. The 
observed behaviour may be due to differences in the susceptibility of cytochrome P450s of rat 
and the two invertebrate species toward ketoconazole inhibition. However, this cannot be 
estimated by the present model, as in silico affinities are estimated with human and fungal 
cytochrome P450 structures.   
Experimental determination of very high inhibition strengths, such as those found for 
clotrimazole and ketoconazole, may be subject to large uncertainties due to experimental 
procedures and biological variation. In order to test experimental variability of the measured 
inhibition strengths, measurements of IC50 with imidazoles were repeated in rat liver microsomes 
with a different batch and chemical stock solutions. The new values are comparable to the 
previous, being in the same order of magnitude and presenting the same ranking among the five 
imidazoles tested (bifonazole: 0.19±0.03 µM, clotrimazole: 0.004±0.003 µM, imazalil: 0.54± 
µM, ketoconazole: 0.28±0.09 µM and prochloraz: 0.37±0.07 µM) (Figure S16) thus showing an 
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acceptable inter-experimental variability when measuring low inhibition strengths with the 
current method. 
 
Conclusions 
Taken together, the use of in vitro measurements with commercially available rat liver 
microsomes and to a lesser extent in silico estimated affinities seems to be a promising tool to 
identify inhibition of cytochrome P450 activity by azoles in C. riparius. On the other hand, L. 
stagnalis presents a very different enzymatic susceptibility toward azole inhibition and no 
extrapolation from either measurement in rat liver or estimated in silico affinities can be made. 
At present, only direct measurements of cytochrome P450 activity in vitro for L. stagnalis can be 
used to estimate inhibition strengths of azole fungicides in this species. Moreover, it is still an 
open question whether the suggested applicability of in silico and in vitro models for C. riparius 
holds for other species, or if the observed unsuitability for L. stagnalis is the norm, rather than 
the exception. 
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FIGURES  
A B  
[COLORED FIGURE]  
Figure 1. Examples of the predicted pose of an azole fungicide (prochloraz) docked into a 
cytochrome P450 active pocket (CYP3A4 PDB 2V0M) with unconstrained (A) and constrained 
docking (B). Note that with constrained docking, the nitrogen (indicated by the red arrow) of the 
azole ring (red shaded circle) is positioned directly above the heme-iron (orange sphere), 
resembling the suggested inhibiting pose of azole fungicides. Oxygen, chlorine and nitrogen 
atoms are represented by red, green and light-blue thick sticks. The carbon atoms in the 
cytochrome P450 structure and heme-group are represented by thin or thick gray sticks, 
respectively. The carbon atoms in the azole molecule are represented by thick dark-blue sticks.  
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Figure 2. Correlations between inhibition strengths of triazole fungicides (white symbols) and 
imidazole fungicides (black symbols) toward rat liver ECOD activity (in logIC50 µM) (n = 17) 
and docking scores obtained with constrained docking into human CYP2C9, CYP2D6 and 
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CYP3A4 and fungal CYP51. “r” denotes Pearson correlation coefficients. * denotes a 
statistically significant correlation. Correlations were not found to be significantly different 
among one another (Z test, p > 0.05). Clotrimazole (§) was not included in the correlation 
analysis. 
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Figure 3. Correlations between inhibition strengths of triazole fungicides (white symbols) and 
imidazole fungicides (black symbols) toward C. riparius (n = 9) ECOD activity (in logIC50 µM) 
and docking scores obtained with constrained docking into human CYP2C9, CYP2D6 and 
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CYP3A4 and fungal CYP51. “r” and “rsp” denote Pearson or Spearman correlation coefficients, 
respectively. * denotes a statistically significant correlation. Clotrimazole (§) and ketoconazole 
(#) were not included in the correlation analysis. 
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Figure 4. Correlations between inhibition strengths of triazole fungicides (white symbols) and 
imidazole fungicides (black symbols) toward L. stagnalis (n = 8) ECOD activity (in logIC50 µM) 
and docking scores obtained with constrained docking into human CYP2C9, CYP2D6 and 
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CYP3A4 and fungal CYP51. “r” and “rsp” denote Pearson or Spearman correlation coefficients, 
respectively. * denotes a statistically significant correlation. Clotrimazole (§) and ketoconazole 
(#) were not included in the correlation analysis. 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 41 
 
AC
CE
PT
ED
 M
AN
US
CR
IPT
 42 
Figure 5. Comparison between inhibition strengths of azole fungicides (imidazoles are shown by 
black circles and triazoles by white circles) in rat liver, C. riparius and L. stagnalis, estimated as 
half maximal inhibition concentrations of cytochrome P450 ECOD activity (in logIC50 µM). 
Clotrimazole (§) was not included in the correlation and regression analyses, while ketoconazole 
(#) was included. 
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Table 1. Azole fungicides used in the present study, type (I: imidazole, T: triazole), use (M: 
medicine, A: agriculture), CAS number, purity, molecular weight, predicted logP (computed by 
Chemicalize,46 based on Viswanadhan, et al. 47), number of stereoisomers and experimentally 
measured inhibition strengths toward cytochrome P450 ECOD activity of rat liver, C. riparius 
larvae and L. stagnalis (IC50 ± SE).  
Name  Type Use CAS Purity 
(%) 
Molecular 
Weight 
Predicted 
logP 
Isomers IC50 Rat liver 
(µM) 
IC50 
C. riparius 
(µM) 
IC50 
L. 
stagnalis 
(µM) 
Bifonazole  I M 60628-
96-8 
≥ 98% 310.39 5.23 2 0.14±0.01 0.08±0.01 11±2 
Clotrimazole  I M 23593-
75-1 
99.6% 344.84 5.84 1 0.0032±0.0008 0.24±0.12 2.3±0.6 
Cyproconazole  T A 94361-
06-5 
99.6% 291.78 2.85 4 8.4±0.6 n.m. n.m. 
Difenoconazole  T A 119446-
68-3 
97.2% 406.26 4.86 4 0.27±0.03 0.68±0.05 46±14 
Epoxiconazole  T A 135319-
73-2 
99.0% 329.76 3.74 4 2.0±0.2 6.2±0.3 n.m. 
Fenbuconazole  T A 114369-
43-6 
99.6% 336.82 4.35 2 3.0±0.3 n.m. n.m. 
Fluconazole  T M 86386-
73-4 
≥ 98% 306.27 0.56 1 26±4 n.m. n.m. 
Flusilazole T A 85509-
19-9 
99.8% 315.39 4.68 1 0.53±0.07 0.17±0.04 57±12 
Imazalil  I M 58594-
72-2 
≥ 98% 297.18 3.76 2 0.6±0.2 0.10±0.01 7±1 
Ketoconazole  I M 65277-
42-1 
≥ 98% 531.43 4.19 4 0.21±0.04 0.50±0.08 142±17 
Myclobutanil  T A 88671-
89-0 
99.4% 288.78 3.66 2 11±1 n.m. n.m. 
Penconazole  T A 66246-
88-6 
≥ 98% 284.18 4.19 2 1.7±0.2 3.9±0.4 4.9±0.5 
Prochloraz  I A 67747-
09-5 
98.6% 376.67 3.62 1 0.26±0.03 0.074±0.006 8±3 
Propiconazole  T A 60207-
90-1 
99.1% 342.22 4.33 4 1.29±0.09 3.7±0.2 10±2 
Tebuconazole  T M 107534-
96-3 
99.3% 307.82 3.69 2 4.4±0.5 18±1 16±2 
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Tetraconazole  T A 112281-
77-3 
99.1% 372.15 3.96 2 4.7±0.3 n.m. n.m. 
Triadimefon  T A 43121-
43-3 
99.5% 293.74 3.97 2 16±4 n.m. n.m. 
Triadimenol  T A 55219-
65-3 
98.7% 295.76 3.28 4 8±1 n.m. n.m. 
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